BRUSELIX BRUISING- vitamin c, zinc, arnica montana extract, bromelain, diosmin, rutin, citrus bioflavonoids, hesperidin methyl chalcone tablet

Bruselix Bruising by

Drug Labeling and Warnings

Bruselix Bruising by is a Prescription medication manufactured, distributed, or labeled by Puretek Corporation. Drug facts, warnings, and ingredients follow.

Drug Details [pdf]

DESCRIPTION:

Active Ingredients
Each tablet contains:
Vitamin C (as Sodium Ascorbate) ...............................................................120 mg
Zinc (as Zinc Picolinate) ...............................................................................10 mg
Arnica Montana Extract 10:1 (equivalent to 500 mg Arnica Montana Powder) ...50 mg
Bromelain 2400 GDU/g (from Pineapple) ...................................................400 mg
Diosmin (Citrus Aurantium) Fruit Extract.....................................................200 mg
Rutin (Sophora Japonica) Flower Extract......................................................50 mg
Citrus Bioflavonoids (from pulp and peel of lemon, orange, quince) ............25 mg
Hesperidin Methyl Chalcone..........................................................................25 mg

Other Ingredients: Croscarmellose Sodium, Dicalcium Phosphate, Magnesium Stearate, Microcrystalline Cellulose, Silicon Dioxide, Stearic Acid (Vegetable Source), Coating (Hydroxypropyl Methylcellulose, PEG-8).

INDICATIONS AND USAGE:

Bruselix™ Bruising Tablets are formulated to provide nutritional support during the body’s natural recovery process. They may be helpful for individuals experiencing bruising due to minor injuries, surgical procedures, or sensitive skin. The formula contains antioxidants, enzymes, and natural extracts that are traditionally used to support overall skin health and recovery.

CONTRAINDICATIONS:

Do not use if you have a known allergy to any of the ingredients in Bruselix™ Bruising Tablets, including Arnica Montana or pineapple (Bromelain). Avoid use if you have an allergy to citrus or bioflavonoid components.

WARNINGS AND PRECAUTIONS

Arnica: May cause allergic reactions in sensitive individuals, especially if there is a history of ragweed allergies.

Bromelain: May increase the risk of bleeding in individuals taking anticoagulants or antiplatelet medications. Discontinue use two weeks before surgery.

Zinc and Vitamin C: Use cautiously in individuals with kidney disease or those prone to kidney stones. If you experience an allergic reaction or prolonged bleeding, discontinue use and seek medical attention immediately.

For use on the order of a licensed healthcare practitioner.

Call your doctor about side effects. To report side effects, call PureTek Corporation at 1-877-921-7873.

Drug Interactions:

The use of anticoagulants, such as warfarin or aspirin, may increase the risk of bleeding when combined with Bromelain. High doses of zinc can interfere with the absorption of iron when taken alongside iron supplements. Additionally, citrus bioflavonoids have the potential to enhance the effects of blood pressure-lowering medications.

Adverse Reactions:

Adverse reactions associated with the use of Bruising Tablets may include mild gastrointestinal discomfort, nausea, or allergic reactions such as skin rash. In rare cases, more serious reactions, such as prolonged bleeding or hypersensitivity reactions (e.g., difficulty breathing, swelling), may occur. If you experience any serious adverse effects, discontinue use and seek medical attention immediately.

OVERDOSE:

In the event of overdose, seek medical attention immediately. Symptoms of overdose may include gastrointestinal upset, nausea, or an increased risk of bleeding due to excess Bromelain.

DOSAGE AND ADMINISTRATION:

Take one (1) Bruselix™ Bruising Tablets daily, or as directed by a licensed healthcare practitioner. Do not exceed recommended dose.

HOW SUPPLIED:

Bruselix™ Bruising Tablets are yellow to brown speckled, clear-coated tablets, packaged in a bottle containing 14 tablets – NDC: 59088-003-81.

KEEP THIS AND ALL MEDICATIONS OUT OF THE REACH OF CHILDREN. Store at 20°-25°C (68°-77°F) [see USP Controlled Room Temperature]

LABEL

Manufactured by:
PureTek Corporation
Panorama City, CA 91402
For questions or information
call toll-free: 877-921-7873

INGREDIENTS AND APPEARANCE

BRUSELIX BRUISING 
vitamin c, zinc, arnica montana extract, bromelain, diosmin, rutin, citrus bioflavonoids, hesperidin methyl chalcone tablet

Product Information
Product Type	HUMAN PRESCRIPTION DRUG	Item Code (Source)	NDC: 59088-003
Route of Administration	ORAL

Active Ingredient/Active Moiety
Ingredient Name	Basis of Strength	Strength
ARNICA MONTANA FLOWER (UNII: OZ0E5Y15PZ) (ARNICA MONTANA FLOWER - UNII:OZ0E5Y15PZ)	ARNICA MONTANA FLOWER	50 mg
STEM BROMELAIN (UNII: ZLM4P8929R) (STEM BROMELAIN - UNII:ZLM4P8929R)	STEM BROMELAIN	400 mg
SODIUM ASCORBATE (UNII: S033EH8359) (ASCORBIC ACID - UNII:PQ6CK8PD0R)	ASCORBIC ACID	120 mg
HESPERIDIN METHYLCHALCONE (UNII: 4T2GVA922X) (HESPERIDIN - UNII:E750O06Y6O)	HESPERIDIN	25 mg
RUTIN (UNII: 5G06TVY3R7) (RUTIN - UNII:5G06TVY3R7)	RUTIN	50 mg
DIOSMIN (UNII: 7QM776WJ5N) (DIOSMIN - UNII:7QM776WJ5N)	DIOSMIN	200 mg
HESPERIDIN (UNII: E750O06Y6O) (HESPERIDIN - UNII:E750O06Y6O)	HESPERIDIN	25 mg
ZINC PICOLINATE (UNII: ALO92O31SE) (ZINC CATION - UNII:13S1S8SF37)	ZINC CATION	10 mg

Inactive Ingredients
Ingredient Name	Strength
MAGNESIUM STEARATE (UNII: 70097M6I30)
STEARIC ACID (UNII: 4ELV7Z65AP)
POLYETHYLENE GLYCOL 400 (UNII: B697894SGQ)
MICROCRYSTALLINE CELLULOSE 102 (UNII: PNR0YF693Y)
DIBASIC CALCIUM PHOSPHATE DIHYDRATE (UNII: O7TSZ97GEP)
SILICON DIOXIDE (UNII: ETJ7Z6XBU4)
HYPROMELLOSE, UNSPECIFIED (UNII: 3NXW29V3WO)
CROSCARMELLOSE SODIUM (UNII: M28OL1HH48)

Product Characteristics
Color	brown (yellow to brown speckled)	Score	no score
Shape	CAPSULE (oblong caplet)	Size	22mm
Flavor		Imprint Code
Contains

Packaging
#	Item Code	Package Description	Marketing Start Date	Marketing End Date
1	NDC: 59088-003-81	14 in 1 BOTTLE, PLASTIC; Type 0: Not a Combination Product	10/11/2024

Marketing Information
Marketing Category	Application Number or Monograph Citation	Marketing Start Date	Marketing End Date
unapproved drug other		10/11/2024

Labeler - Puretek Corporation (785961046)